A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 6, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2027

Conditions
B-cell Lymphoma
Interventions
DRUG

TQB3702 tablets+Chemotherapy regimen

"TQB3702 tablets: Tyrosine kinase inhibitor;~Chemotherapy regimen:inhibiting tumor cell proliferation, suppressing DNA synthesis, inducing cell apoptosis, enhancing immune system function, and inhibiting angiogenesis;"

Trial Locations (30)

10000

NOT_YET_RECRUITING

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

100021

NOT_YET_RECRUITING

Cancer Hospital Chinise Academy of Medical Sciences, Beijing

116000

NOT_YET_RECRUITING

The second Hospital of dalian, Dalian

150000

NOT_YET_RECRUITING

Harbin Medical University Cancer Hospital, Harbin

200063

NOT_YET_RECRUITING

Tongji Hospital of Tongji University, Shanghai

210000

NOT_YET_RECRUITING

Jiangsu Provincial People's Hospital, Nanjing

250117

RECRUITING

Affiliated Cancer Hospital of Shandong First Medical University, Jinan

271000

NOT_YET_RECRUITING

Tai'an Central Hospital, Tai’an

300122

NOT_YET_RECRUITING

Tianjin People's Hospital, Tianjin

300202

NOT_YET_RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

330006

NOT_YET_RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

410013

NOT_YET_RECRUITING

Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha

412000

NOT_YET_RECRUITING

Zhuzhou Central Hospital, Zhuzhou

430022

NOT_YET_RECRUITING

Union Hosiptal, Tongji Medical College, Huazhong University of Science And Technolocy, Wuhan

430030

NOT_YET_RECRUITING

Tongji Hospital Tongji Medical College of HUST, Wuhan

441000

NOT_YET_RECRUITING

Xiangyang Central Hospital, Xiangyang

450000

NOT_YET_RECRUITING

PuYang AnYang District Hospital, Anyang

NOT_YET_RECRUITING

Henan Provincial People's Hospital, Zhengzhou

457000

NOT_YET_RECRUITING

Puyang People's Hospital, Puyang

NOT_YET_RECRUITING

Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou

510000

NOT_YET_RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

530021

NOT_YET_RECRUITING

Guangxi Medical University Cancer Hospital, Nanning

NOT_YET_RECRUITING

Guangxi Medical University Cancer Hospital, Nanning

537000

NOT_YET_RECRUITING

Guigang City People's Hospital, Guigang

643000

NOT_YET_RECRUITING

Zigong First People's Hospital, Zigong

646000

NOT_YET_RECRUITING

The Affiliated Hospital of Southwest Medical University, Luzhou

710004

NOT_YET_RECRUITING

The Second Affiliated Hospital Of Xi'an Jiaotong University(Xibei Hospital), Xi'an

730000

NOT_YET_RECRUITING

Gansu Provincial Cancer Hospital, Lanzhou

830000

NOT_YET_RECRUITING

Affiliated Tumor Hospital of Xinjiang Medical University, Ürümqi

030000

NOT_YET_RECRUITING

Shanxi Cancer Hospital, Taiyuan

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY